VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma.
Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA).
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA).
Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA). Mol Cancer Ther. 2017 06; 16(6):1114-1123.
View in:
PubMed
subject areas
Animals
Biomarkers
Drug Evaluation, Preclinical
Female
Humans
Liposomes
Macaca mulatta
Male
Mice
Nanoparticles
Phosphatidylcholines
Receptor, EphA2
RNA Interference
RNA, Small Interfering
Tissue Distribution
authors with profiles
WALLACE BAZE
ANIL K SOOD
MARK J MCARTHUR
ROBERT COLEMAN
SHERRY WU